List of Excipients in API efavirenz, lamivudine and tenofovir disoproxil fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing efavirenz, lamivudine and tenofovir disoproxil fumarate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Mylan Specialty LP | SYMFI LO | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 | CELLULOSE, MICROCRYSTALLINE | |
| Mylan Specialty LP | SYMFI LO | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 | CROSCARMELLOSE SODIUM | |
| Mylan Specialty LP | SYMFI LO | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 | FERRIC OXIDE YELLOW | |
| Mylan Specialty LP | SYMFI LO | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 | HYDROXYPROPYL CELLULOSE | |
| Mylan Specialty LP | SYMFI LO | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 | LACTOSE MONOHYDRATE | |
| Mylan Specialty LP | SYMFI LO | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing efavirenz, lamivudine and tenofovir disoproxil fumarate
Detailed excipient profiles for efavirenz, lamivudine and tenofovir disoproxil fumarate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing CROSCARMELLOSE SODIUM
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-929 |
| Mylan Specialty LP | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 |
| >Company | >Ingredient | >NDC |
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-928 |
| Mylan Specialty LP | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-475 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing HYDROXYPROPYL CELLULOSE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-928 |
| >Company | >Ingredient | >NDC |
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing LACTOSE MONOHYDRATE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-928 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing MAGNESIUM STEARATE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Specialty LP | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 |
| Mylan Specialty LP | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-475 |
| >Company | >Ingredient | >NDC |
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-928 |
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-929 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-928 |
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-929 |
| >Company | >Ingredient | >NDC |
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Specialty LP | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-425 |
| Mylan Specialty LP | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-475 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing POLYVINYL ALCOHOL
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Specialty LP | efavirenz, lamivudine and tenofovir disoproxil fumarate | 49502-475 |
| >Company | >Ingredient | >NDC |
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM LAURYL SULFATE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing SODIUM LAURYL SULFATE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Laurus Labs Limited | efavirenz, lamivudine and tenofovir disoproxil fumarate | 42385-928 |
| >Company | >Ingredient | >NDC |
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing STARCH, CORN
Excipient focus: TALC
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing TALC
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants containing TITANIUM DIOXIDE
efavirenz, lamivudine and tenofovir disoproxil fumarate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
